Insiders say Siemens is considering a merger of its railway business with Canadian rival Bombardier – a move that could cost more jobs in an already losing industry.
According to WirtschaftsWoche, a sister publication of Handelsblatt, the two businesses have been in discussions for months. The goal is to form a new, joint company combining the railway car, locomotives and control technology as well as subway and streetcar divisions. Siemens has already adopted a similar strategy with Gamesa, the Spanish wind energy equipment manufacturer.
The move could prove to be sensible. With joint revenues of nearly €15 billion (US$18 billion), the companies could become a stronger counterweight to the Chinese state-run company CRRC, which had annual sales of more than €32 billion (US$36 billion) after currency conversion and is already successfully marketing its railway technology in developing countries across Southeast Asia and the Middle East.
“It won’t be too far in the future when China is also permitted to sell its products in Europe,” said Andreas Matthä, chief executive of Austrian National Railway (ÖBB).
Full Content: The Guardian
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas